| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/14/2006 | EP1117423B1 Immortalized human keratinocyte cell line |
| 06/14/2006 | EP1102742B1 Compounds and compositions for delivering active agents |
| 06/14/2006 | EP1102596B1 Peptide antagonists of zonulin and methods for use of the same |
| 06/14/2006 | EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 06/14/2006 | EP1071468B1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 06/14/2006 | EP1069890B1 Incorporation of active substances in carrier matrixes |
| 06/14/2006 | EP1045926B1 Gene family with transformation modulating activity |
| 06/14/2006 | EP1033373B1 Feline granulocyte colony-stimulating factor |
| 06/14/2006 | EP1032696B1 Vector for tissue-specific replication and gene expression |
| 06/14/2006 | EP0964869B1 Methods and compositions for the treatment of neoplastic diseases |
| 06/14/2006 | EP0934072B1 Manufacturing process for the production of purified transferrin |
| 06/14/2006 | EP0913404B1 Differentiation inhibitor |
| 06/14/2006 | EP0879035B1 Bismuth-containing compositions in topical dosage forms |
| 06/14/2006 | EP0795605B1 Denatured low-density lipoprotein receptor |
| 06/14/2006 | EP0783321B1 Vr-2332 viral nucleotide sequence and methods of use |
| 06/14/2006 | EP0777687B1 Trefoil peptide dimer |
| 06/14/2006 | EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES |
| 06/14/2006 | EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 06/14/2006 | EP0666868B2 Use of anti-VEGF antibodies for the treatment of cancer |
| 06/14/2006 | DE19941897B4 IL-6 Rezeptor-Protein, Beta-Kette (gp130) des IL-6 Rezeptor-Proteins, für diese Proteine kodierende DNA, davon abgeleitete RNA, Peptid mit den Aminosäuren 771-811 dieser Beta-Kette oder Teilen davon und deren Verwendungen IL-6 receptor protein beta-chain (gp130) of the IL-6 receptor protein, DNA encoding for these proteins, derived RNA, peptide with the amino acids 771-811 of the beta-chain or parts thereof and their uses |
| 06/14/2006 | DE102005016229B3 Dry atomizer, useful for atomizing a medicament preparation, comprises a housing, a gas pipeline with gas inlet, and a gas deflection with gas outlet, which acts as a filter |
| 06/14/2006 | CN1788088A Mutant vesicular stomatitis viruses and use thereof |
| 06/14/2006 | CN1788086A Antisense oligonucleotides (ODN) against smad7 and uses in medical field thereof |
| 06/14/2006 | CN1788081A Anti cancer target direction adjustable gene-virus and structure method thereof |
| 06/14/2006 | CN1788017A Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 06/14/2006 | CN1787840A Drug for treating hemophilia and method of treating hemophilia using the same |
| 06/14/2006 | CN1787837A Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/14/2006 | CN1787834A One or several enzyme-containing compounds, dietetic food products and drugs produced from said compounds and the use therefor for medical purposes |
| 06/14/2006 | CN1787833A Pharmaceutical preparations comprising acid-stabilised insulin |
| 06/14/2006 | CN1787832A Method of treating inflammtory disease associated with bone destruction |
| 06/14/2006 | CN1787831A Methods for preventing mitochondrial permeability transition |
| 06/14/2006 | CN1787830A Compositions for delivering peptide YY and PYY agonists |
| 06/14/2006 | CN1787829A Composition against infection with rotavirus and process for producing the same |
| 06/14/2006 | CN1787828A Heterocarpin, a plant-derived protein with anti-cancer properties |
| 06/14/2006 | CN1787824A External preparation for improving coital function |
| 06/14/2006 | CN1787820A Composition for improving cognition and memory |
| 06/14/2006 | CN1787813A Treatment and/or prevention of non-viral epithelial damage |
| 06/14/2006 | CN1787812A Insoluble globin injectable implant |
| 06/14/2006 | CN1787741A Methods and compositions for the prevention and treatment of sepsis |
| 06/14/2006 | CN1786167A Polypeptide of anti HIV virus and its coding gene and application |
| 06/14/2006 | CN1786031A Glucagon kind polypeptide-1 analogue, its preparation method and application |
| 06/14/2006 | CN1786020A Inhibition peptide of hepatatitis B virus polyzymoprotein YMDD functional region and its application |
| 06/14/2006 | CN1786017A Renaturation of reconstituted human bone protein-1 and making method of its preparation |
| 06/14/2006 | CN1785432A Chromatin peptide medicinal molecule for sealing MYC cell proliferation path |
| 06/14/2006 | CN1785428A New lysozyme compound injection preparation |
| 06/14/2006 | CN1785427A Compound calcium preparation for astronaut |
| 06/14/2006 | CN1785426A Method of inhibiting neonate tumour blood vessel |
| 06/14/2006 | CN1785425A Preparation method of poly peptide vaccine for treating lefteye flounder adenolymphocele |
| 06/14/2006 | CN1785424A Bone growth penta peptide medicinal composition ant its preparation method |
| 06/14/2006 | CN1785214A Extractives of pearl nacre mother protein and its application |
| 06/14/2006 | CN1785153A Nano-grade material prepn. apparatus, and method for preparing nano-anti-oxidation active poly peptide medicine |
| 06/14/2006 | CN1785062A Drinking water for health-care and sports and its prepn. method |
| 06/14/2006 | CN1259420C Sea anemone neurotoxin gene Sr3 and application thereof |
| 06/14/2006 | CN1259419C Sea anemone neurotoxin gene Sr2 and application thereof |
| 06/14/2006 | CN1259418C Coding recombinant adenoviruses for iodine specific transport protein |
| 06/14/2006 | CN1259411C Strain of Pichia yeast genetic engineering, preparation method and application |
| 06/14/2006 | CN1259340C Peptide composition as immunogen for treatment of allergy |
| 06/14/2006 | CN1259337C Synthesis, expression, preparation and application for human parathyroid hormone gene mutant |
| 06/14/2006 | CN1259105C Buccal tablet of recombined human interferon alpha 2b and producing method |
| 06/14/2006 | CN1259104C Oromucosal cytokine compositions and uses thereof |
| 06/14/2006 | CN1259103C Prescription of medicine for preventing and treating fin rot of turbot |
| 06/14/2006 | CN1259063C Method for preparing non-specific immunity activator |
| 06/14/2006 | CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 06/13/2006 | US7060871 Use of exogenous β-adrenergic receptor and β-adrenergic receptor kinase gene constructs to enhance myocardial function |
| 06/13/2006 | US7060810 Regulation of human eosinophil serine protease 1-like enzyme |
| 06/13/2006 | US7060808 Epidermal growth factor; nucleic acids, protein which binds to epidermal growth factor receptors; genetic engineering |
| 06/13/2006 | US7060805 Methods for isolating tissue factor inhibitor |
| 06/13/2006 | US7060801 Antibodies to human growth factor huXAG-3 and methods of use |
| 06/13/2006 | US7060800 Polypeptides for use in the treatment and diagnosis of crohn's disease |
| 06/13/2006 | US7060797 Using isolated polypeptide, polynucleotide; antibodies, epitopes that bind to these |
| 06/13/2006 | US7060795 Comprises nucleotide sequences coding matrix metalloprotease enzyme inhibitors for use in the treatment of injuries; wound healing agents |
| 06/13/2006 | US7060792 Protection against ischemia and reperfusion injury |
| 06/13/2006 | US7060791 Genetic engineering; bone disorders; anticancer agent |
| 06/13/2006 | US7060790 Genetic engineering; antitumor agents; therapy for microbiocide infections; antiinflammatory agents; immunology |
| 06/13/2006 | US7060789 Ricin-like toxins for treatment of cancer |
| 06/13/2006 | US7060727 Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof |
| 06/13/2006 | US7060719 Glutaminyl based DPIV inhibitors |
| 06/13/2006 | US7060690 For therapy of cancer |
| 06/13/2006 | US7060688 A gene therapy for cancers, comprising a cancer suppressing gene; genetic engineering, duplicated gene, cloned gene |
| 06/13/2006 | US7060684 site-specifically treating a diabetic foot by implanting a composite supported vascular graft comprising an angiogenesis factor, e.g., vascular endothelial growth factor and/or platelet derived growth factor |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | US7060682 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes |
| 06/13/2006 | US7060681 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 06/13/2006 | US7060680 Compositions for maintaining the integrity of the gastrointestinal tract luminal lining in a mammal, including (1) limiting epithelial cell proliferation, (2) inhibiting ulcerative lesion formation, (3) inhibiting inflammation |
| 06/13/2006 | US7060679 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 06/13/2006 | US7060678 peptidomimetic analogs of VIP receptor binding inhibitors replacing the di-/tri-peptides having proline as one of the amino acids, or proline alone, with at leat one unit from enantiomorphic 4-(aminomethyl)tetrahydrofuran-2-carboxylic acid |
| 06/13/2006 | US7060677 Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 06/13/2006 | US7060676 Administering a therapeutically effective amount Trypanosoma cruzi trans-sialidase or a neurotrophic variant; amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, Chagas' disease, peripheral neuropathy, |
| 06/13/2006 | US7060675 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes |
| 06/13/2006 | US7060674 Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| 06/13/2006 | US7060673 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same |
| 06/13/2006 | US7060672 Cyclosporin analog formulations |
| 06/13/2006 | US7060671 Peptides containing N-substituted D-amino acids for preventing β-strand association |
| 06/13/2006 | US7060670 having a sequence identified from the glycosaminoglycan (GAG) binding region and the prot prot interaction region of the amylo protein and having at least one amino acid isomer substitution; for inhibiting amyloidosis and/or for cytoprotection |
| 06/13/2006 | US7060669 in aqueous two-phase systems by fusing hydrophobin or hydrophobin-like protein to a protein of interest, such as an extracellular protein of Trichoderma, selected from the group consisting of cellulases, hemicellulases and proteases. |
| 06/13/2006 | US7060667 administering a soluble lymphotoxin-beta receptor, which may be fused to one or more heterologous protein domains, such as a human immunoglobulin Fc domain, optionally incombination with chemotherapy, radiotherapy or bone marrow transplant |
| 06/13/2006 | US7060504 High mobility group proteins; diagnostic monitoring the severity or potential lethality of sepsis or septic shock, measuring the serum protein concentration of patient, treating weight loss or obesity |
| 06/13/2006 | US7060495 Polypeptide for use in as anticarcinogenic agent |
| 06/13/2006 | US7060484 Polypeptides and coagulation therapy |
| 06/13/2006 | US7060483 DNA encoding endo-β-galactosidase |